MedPath

YourChoice Therapeutics, Inc.

YourChoice Therapeutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2018-01-01
Employees
11
Market Cap
-
Website
http://www.yourchoicetx.com

Open Label, Repeat Dose Study Evaluating YCT-529 in Healthy Males

Phase 1
Recruiting
Conditions
Male Contraception
Interventions
First Posted Date
2024-08-07
Last Posted Date
2025-04-13
Lead Sponsor
YourChoice Therapeutics, Inc.
Target Recruit Count
66
Registration Number
NCT06542237
Locations
🇳🇿

New Zealand Clinical Research (NZCR), Grafton, Auckland, New Zealand

First in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males

Phase 1
Completed
Conditions
Male Contraception
Interventions
Drug: YCT-529 Placebo
First Posted Date
2023-10-23
Last Posted Date
2024-10-02
Lead Sponsor
YourChoice Therapeutics, Inc.
Target Recruit Count
16
Registration Number
NCT06094283
Locations
🇬🇧

Quotient Sciences, Nottingham, East Midlands, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath